Document is current

Any future updates will be listed below

Piperacillin/tazobactam versus carbapenems for 30-day mortality in patients with ESBL-producing Enterobacterales bloodstream infections: a retrospective, multicenter, non-inferiority, cohort study

Crossref DOI link: https://doi.org/10.1007/s15010-025-02496-x

Published Online: 2025-04-16

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark